Physician profile
Gary Gerard Bucher
NPI 1770664856
$54,111.10
in general payments reported to CMS, 2019-2025
6 companies · $23K in 2025
The $23K reported for 2025 was more than what 99% of Adult Medicine providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.91 · 2022: $24.15 · 2023: $183 · 2024: $31K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $35K · Travel and Lodging: $14K · Food and Beverage: $4,537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $35,100.00 |
| Travel and Lodging | $14,358.56 |
| Food and Beverage | $4,537.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thd America, INC. | $53,558.85 | 2023-2025 | |
| Edwards Lifesciences Corporation | $158.26 | 2024 | Sapien 3 Ultra Resilia |
| Viiv Healthcare Company | $142.42 | 2024-2025 | Dovato |
| Gilead Sciences, INC. | $119.89 | 2025 | |
| Merck Sharp & Dohme LLC | $115.06 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $16.62 | 2023 | Symtuza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Bucher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.